A significant number of individuals with type 2 diabetes (T2DM) develop cognitive deficits over time that in some cases could lead to dementia. It remains to be identified the diabetes-related factors or comorbid conditions that drive the association and how they work. In this manuscript, we show that 14-15 month-old hAPP NL/F mice, a knock‐in mouse model of preclinical Alzheimer’s disease (AD) (that is, they generate Aβ42 at an early age but do not show symptoms of the disease until they are old), but not wild type, develop behavioural deficits that correlate with electrophysiological and dendritic spine changes when affected by T2DM. The deficits are not paralleled by higher levels of toxic forms of amyloid beta-peptide (Aβ) or by neuroinflammation but by a reduction in γ-secretase activity, in turn accountable, among other consequences, for a reduction in the levels of the synaptogenesis regulator protein PSD95, and by increased phosphorylation of Tau at epitopes of dendritic spine targeting. RNAseq analysis of the cerebral cortex of wild type and hAPP NL/F, with and without T2DM, revealed the significant downregulation of hypoxia inducible factor 3 (HIF-3α) in the hAPP NL/F diabetic mice only, a decrease that was also observed at the protein level. The main conclusion of this work is that T2DM will trigger or accelerate cognitive illness fundamentally in those individuals who already have a genetic predisposition to AD. A second conclusion is that the cognitive disorders produced by diabetes in these individuals are not due to the excess of toxic forms of Aβ but to other causes, including loss of function of γ-secretase. The third conclusion is that an alteration of the response to hypoxia through Hif3α would be mediating the negative effects of T2DM in the brain.
In this work, we tested the hypothesis that the development of dementia in individuals with type 2 diabetes (T2DM) requires a genetic background of predisposition to neurodegenerative disease. As a proof of concept, we induced T2DM in middle-aged hAPP NL/F mice, a preclinical model of Alzheimer’s disease. We show that T2DM produces more severe behavioral, electrophysiological, and structural alterations in these mice compared with wild-type mice. Mechanistically, the deficits are not paralleled by higher levels of toxic forms of Aβ or by neuroinflammation but by a reduction in γ-secretase activity, lower levels of synaptic proteins, and by increased phosphorylation of tau. RNA-seq analysis of the cerebral cortex of hAPP NL/F and wild-type mice suggests that the former could be more susceptible to T2DM because of defects in trans-membrane transport. The results of this work, on the one hand, confirm the importance of the genetic background in the severity of the cognitive disorders in individuals with T2DM and, on the other hand, suggest, among the involved mechanisms, the inhibition of γ-secretase activity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.